Researchers assessed the extent of which vaccine fatigue translates to reduced engagement and adherence among patients.
News|Articles|July 20, 2026
Vaccine Policy in Flux: Stories Pharmacists Need to Follow
Author(s)Ashley Gallagher, MA
Vaccine guidance in the US is undergoing a dramatic change, leaving pharmacists uncertain about coverage, authority, and flu-season timing.
Advertisement
Advertisement
From a presidential executive order to a coalition letter from pharmacy groups, the past several weeks have brought a steady stream of developments in the fight over who controls the US vaccine schedule. Below is a chronological recap of the key stories, tracing how the conflict between the Department of Health and Human Services (HHS), medical societies, and the courts has evolved—and what each turn means for pharmacists administering vaccines on the front lines.
Related to this article
Pharmacist-backed picks help families manage fever and pain, seasonal allergies, and cough and congestion as kids head back to the classroom.
Researchers evaluate peer-reviewed literature on interventions to improve vaccine uptake among thousands of US adults studied between 2010 and 2015.
A case shows a suspected recurrence of pneumococcal disease that ended with removal of one cochlear implant and replacement of the other.
Eli Lilly released phase 2b trial results comparing the investigational eloralintide-tirzepatide combo with tirzepatide 15 mg alone in patients with T2D and obesity.
To guide public health and vaccination strategies, researchers assessed a variety of factors regarding community-acquired pneumonia and its causes.
Highlighting the clinical impact of the pharmacy profession, we caught up with pharmacists of various types to get their perspectives on the evolution of pharmacy.
A newly erected Women’s Health Division within NIH will work in tandem with the Office of Research on Women’s Health.
Advertisement
Advertisement